Identifying Drug-Induced Liver Illness (DILI) with Computerized Information Extraction: No More Dilly-Dallying

被引:0
|
作者
H. Shen
A. Monto
机构
[1] University of California San Francisco (UCSF),Department of Medicine
[2] San Francisco Veterans Affairs Medical Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:564 / 566
页数:2
相关论文
共 50 条
  • [31] Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
    Danjuma, Mohammed
    Elgara, Mohamed
    Al-Hattab, Fatima
    Abaro, Rumaisa
    Elzouki, Abdel-Naser
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (07) : 934 - 935
  • [32] Case of cholestatic drug-induced liver injury (DILI) associated with black cohosh
    Brar, Himmat Singh
    Marathi, Rachana
    BMJ CASE REPORTS, 2021, 14 (05)
  • [33] Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features
    Stephens, C.
    Ortega, A.
    Medina-Caliz, I.
    Diaz, Mercedes Robles
    Castiella, Agustin
    Otazua, Pedro
    Zapata, E.
    Gomez-Moreno, E. M.
    Lopez-Nevot, MAngel
    Ruiz-Cabello, Francisco
    Soriano, German
    Roman, E.
    Hallal, Hacibe
    Maria Moreno-Planas, Jose
    Prieto, Martin
    Lucena, M. I.
    Andrade, Raul J.
    HEPATOLOGY, 2015, 62 : 499A - 499A
  • [34] Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing
    Tatrai, Peter
    Erdo, Franciska
    Krajcsi, Peter
    PHARMACEUTICS, 2023, 15 (01)
  • [35] Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
    Juliana Hey-Hadavi
    Daniel Seekins
    Melissa Palmer
    Denise Coffey
    John Caminis
    Sandzhar Abdullaev
    Meenal Patwardhan
    Haifa Tyler
    Ritu Raheja
    Ann Marie Stanley
    Liliam Pineda-Salgado
    David L. Bourdet
    Raul J. Andrade
    Paul H. Hayashi
    Lara Dimick-Santos
    Don C. Rockey
    Alvin Estilo
    Drug Safety, 2021, 44 : 619 - 634
  • [36] Autoimmune hepatitis (AIH) or drug-Induced liver injury (DILI)-a diagnostic challenge
    Maor, Yaakov
    Abdallah, Ali
    Mendel, Leore Cohen
    Melzer, Ehud
    Malnick, Stephen
    JOURNAL OF HEPATOLOGY, 2023, 78 : S133 - S133
  • [37] Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
    Hey-Hadavi, Juliana
    Seekins, Daniel
    Palmer, Melissa
    Coffey, Denise
    Caminis, John
    Abdullaev, Sandzhar
    Patwardhan, Meenal
    Tyler, Haifa
    Raheja, Ritu
    Stanley, Ann Marie
    Pineda-Salgado, Liliam
    Bourdet, David L.
    Andrade, Raul J.
    Hayashi, Paul H.
    Dimick-Santos, Lara
    Rockey, Don C.
    Estilo, Alvin
    DRUG SAFETY, 2021, 44 (06) : 619 - 634
  • [38] Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
    Kaliyaperumal, Kalaiyarasi
    Grove, Jane I.
    Delahay, Robin M.
    Griffiths, William J. H.
    Duckworth, Adam
    Aithal, Guruprasad P.
    JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 948 - 957
  • [39] Profiles of Leukocytes Infiltrating Livers of Subjects with Drug-Induced Liver Injury (DILI)
    Foureau, David M.
    Walling, Tracy L.
    Kleiner, David E.
    Ahrens, William A.
    Jacobs, W. Carl
    McKillop, Lain H.
    Barnhart, Huiman X.
    Serrano, Jose
    Bonkovsky, Herbert L.
    HEPATOLOGY, 2012, 56 : 596A - 597A
  • [40] RECURRENT DRUG-INDUCED LIVER INJURY (DILI) WITH DIFFERENT DRUGS IN THE SPANISH REGISTRY
    Borraz, Y.
    Castiella, A.
    Stephens, C.
    Hallal, H.
    Fernandez, M. C.
    Perez-Alvarez, R.
    Otazua, P.
    Garcia-Bengoechea, M.
    Berenguer, M.
    Ulzurrun, E.
    Andrade, R. J.
    Lucena, M. I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 39 - 39